Sorafenib in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors

This study is currently recruiting participants.

Study NCT00942682 Information provided by Dana-Farber Cancer Institute

First Received: July 17, 2009 Last Updated: January 27, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	June 2011 (Final data collection date for primary outcome measure)